Genesis Therapeutics is pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.
Location: United States, California, Burlingame
Employees: 11-50
Total raised: $256.099999M
Founded date: 2019
Investors 7
| Date | Name | Website |
| - | Harpoon Ve... | harpoon.vc |
| 20.06.2021 | Open Field... | ofcap.com |
| - | a16z | a16z.com/ |
| 23.12.2020 | Felicis Ve... | felicis.co... |
| - | Radical Ve... | radical.vc |
| 18.06.2020 | JAZZ Ventu... | jazzvp.com |
| - | Propagator... | propagator... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 21.08.2023 | Series B | $200M | T. Rowe Pr... | vcnewsdail... |
| 03.12.2020 | Series A | $52M | - | finsmes.co... |
| 21.11.2019 | Seed | $4.099999M | - | finsmes.co... |
Mentions in press and media 17
| Date | Title | Description | Source |
| 12.10.2023 | Bytes to Bites part three – Wellness wired: Leveraging AI to... | Editor’s Note: Eva Everloo is senior investment analyst and Dr. Anđela Martinović is scientific anal... | agfunderne... |
| 21.08.2023 | A16z-Backed AI Biotech Startup Genesis Therapeutics Raises $... | 10 Shares Email Facebook Twitter LinkedIn Artificial intelligence and biotech are two of the sector... | news.crunc... |
| 21.08.2023 | Genesis Therapeutics Completes $200M Series B | BURLINGAME, CA, Genesis Therapeutics, harnessing AI to create medicines for patients with severe d... | vcnewsdail... |
| 21.08.2023 | Genesis Therapeutics Closes $200M Series B Funding | Genesis Therapeutics, a Burlingame, CA-based artificial intelligence (AI) tech company which special... | finsmes.co... |
| 10.01.2022 | New Year, New Fund, New Opportunities in Bio + Health | 2021 saw higher than ever funding of startups, continued maturation of the tech-enabled bio and heal... | a16z.com/2... |
| 02.12.2020 | Genesis Therapeutics Partners With Genentech For New AI-Focu... | Giuliano J. de Leon, Tech Times 02 December 2020, 12:12 pm Genesis Therapeutics raises a budget of ... | techtimes.... |
| 02.12.2020 | Genesis Therapeutics raises $52M A round for its AI-focused ... | Sifting through the trillions of molecules out there that might have powerful medicinal effects is a... | techcrunch... |
| 02.12.2020 | Genesis Therapeutics : Secures $52M Series A to Further Acce... | Genesis Therapeutics, a company pioneering AI technologies to create medicines for patients with sev... | marketscre... |
| 02.12.2020 | Genesis Therapeutics Secures $52M in Series A | BURLINGAME, CA, Genesis Therapeutics completed its $52M Series A financing round, led by Rock Spri... | vcnewsdail... |
| 02.12.2020 | Genesis Therapeutics Raises $52M in Series A Funding | Genesis Therapeutics, a Burlingame, Calif.-based company pioneering AI technologies to create medici... | finsmes.co... |
Show more